Skip to content

Microvascular flow and microvascular blood volume measurements in human skeletal muscle using contrast enhanced ultrasound (CEUS).

Microvascular flow and microvascular blood volume measurements in human skeletal muscle using contrast enhanced ultrasound (CEUS). - CEUS reproducibility study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38401
Enrollment
12
Registered
2012-04-18
Start date
2012-08-27
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microvascular insulin resistance

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-55 years 2. BMI

Exclusion criteria

Exclusion criteria: 1. Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, heart failure, cardiac shunts, heart valve replacement, pulmonary hypertension). 2. Pulmonary disease. 3. Diabetes mellitus (FPG > 7.8 mmol/L). 4. Smoking. 5. Hypertension (>140/90 mmHg). 6. Alcohol use > 4 U/day. 7. Use of medication (antihypertensive medication, statins, corticosteroids, NSAIDs, ciclosporin A, rifampicin). 8. Pregnancy or lactation. 9. Insufficient knowledge of the Dutch language. 10. Known allergic reaction to ultrasound contrast-agent. 11. Known cardiac dysrhythmias (e.g. atrial fibrillation, long QT-syndrome) or a family history of cardiac dysrhythmias or sudden cardiac death.

Design outcomes

Secondary

MeasureTime frame
1. Inter-observer variability in offline analysis of CEUS measurements. 2. Skeletal muscle microvascular flow distribution. 3. Change in skeletal muscle microvascular flow distribution from baseline to post-exercise status.

Primary

MeasureTime frame
1. Intra-observer variability and day-to-day variation of forearm skeletal muscle CEUS measurements. 2. The percentage change in microvascular blood volume (MBV), flow and flow velocity (MFV), measured by means of CEUS signal, in forearm skeletal muscle from baseline to post-exercise status.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)